Groundbreaking research reveals Mounjaro injections could revolutionise obesity treatment by targeting food addiction mechanisms in the brain, offering new hope for millions struggling with compulsive eating.
A 35-year-old woman shares her incredible 5-stone weight loss journey using diabetes drug Mounjaro, revealing the uncomfortable side effect affecting thousands and the cheap gadget that provided relief.
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
A determined mother from the UK has shed over 10 stone using diabetes medication Mounjaro, completely transforming her life and health in an inspiring weight loss journey.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Broadmoor Hospital prescribes controversial weight-loss injections including Ozempic to dangerous criminals battling obesity, sparking ethical debate about taxpayer-funded treatments for serious offenders.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
A woman's astonishing account reveals how dramatic weight loss transformed her social experience, exposing society's hidden bias toward thinner bodies and raising questions about 'pretty privilege'.
The NHS is poised to prescribe diabetes medication Mounjaro for weight loss in a groundbreaking move that could help millions of Britons struggling with obesity. Health Secretary Wes Streeting announces major expansion of weight management services.
Eli Lilly accuses the UK of having Europe's most challenging drug pricing system, threatening patient access to new medicines like Mounjaro amid ongoing NHS negotiations.
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Exclusive: Carly Stokes, a mother battling severe obesity, is denied access to the 'game-changer' drug Tirzepatide (Mounjaro) on the NHS despite its proven success, sparking outrage and a debate on healthcare funding.
A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.
Medical experts reveal why miracle weight-loss drugs like Ozempic are failing to address the psychological roots of emotional eating, calling for integrated mental health support alongside pharmaceutical treatments.
Former Gogglebox favourite Amy Tapper opens up exclusively about her life-changing 10-stone weight loss journey using diabetes drug Mounjaro, sharing her struggles and triumphs.
A revolutionary new weight loss pill, Survodutide, is making waves in medical trials, with manufacturers boasting it could be twice as effective as blockbuster drugs like Ozempic and Wegovy.
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
A landmark study presented in Vienna shows the diabetes drug tirzepatide (Mounjaro) leads to unprecedented weight loss in NHS patients, offering new hope in the fight against obesity.
A groundbreaking new oral weight loss drug, Orforglipron, could rival Wegovy injections after a UK study showed participants lost over 10% of their body weight. Discover the potential game-changer for obesity treatment.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.